Hikma Pharmaceuticals PLC (LON:HIK)

Hikma Pharmaceuticals Revenue

In the year 2025, Hikma Pharmaceuticals had annual revenue of $3.35B USD with 7.10% growth. Hikma Pharmaceuticals had revenue of $1.69B in the half year ending December 31, 2025, with 16.78% growth.

• Revenue: $3.35B
• Revenue Growth: +7.10%
• P/S Ratio: 1.22
• Revenue / Employee: $356.28K
• Employees: 9,400
• Market Cap: 3.03B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.35B	222.00M	7.10%
Dec 31, 2024	3.13B	252.00M	8.77%
Dec 31, 2023	2.88B	358.00M	14.22%
Dec 31, 2022	2.52B	-36.00M	-1.41%
Dec 31, 2021	2.55B	212.00M	9.06%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 30, 2026

Data Sources Report a data error